China Nuokang Bio-Pharmaceutical Inc. Announces Participation in Upcoming Conferences BEIJING, May 7, 2010 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...

China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2009 Financial Results Baquting Sales Drive Strong 4Q09 Revenue and Net Income Performance  4Q09 Revenue up 15.3% to RMB82.9 Million YOY 4Q09 Non-GAAP Net Income as Adjusted up 30.9% to RMB30.6 Million YOY...

China Nuokang Bio-Pharmaceutical Inc. to Report Fourth Quarter and Full Year 2009 Financial Results BEIJING, March 9, 2010 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...

China Nuokang Bio-Pharmaceutical Inc. Announces Pricing of Initial Public Offering on the NASDAQ Global Market BEIJING, Dec. 9, 2009 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research,...